Olga Riabova

Quantitative Structure−Activity Relationship Studies of [(Biphenyloxy)propyl]isoxazole Derivatives. Inhibitors of Human Rhinovirus 2 Replication

V. Е. Kuz’min, A. G. Artemenko, Eugene Muratov et al. · Journal of Medicinal Chemistry · 2007 · 71 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis

Jérémie Piton, Anthony Vocat, Andréanne Lupien et al. · Antimicrobial Agents and Chemotherapy · 2018 · 67 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo

Viola Camilla Scoffone, Laurent R. Chiarelli, Vadim Makarov et al. · Scientific Reports · 2016 · 56 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3

Michaela Schmidtke, Peter Wutzler, Romy Zieger et al. · Antiviral Research · 2008 · 53 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment

Michaela Schmidtke, Elke Hammerschmidt, Susanne Schüler et al. · Journal of Antimicrobial Chemotherapy · 2005 · 52 citations

Life Sciences, Infectious Diseases, Microbiology +17